Reaction

Oral Administration Complication reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 927 reports · 5 co-occurring drugs

As of the last recalculation, Oral Administration Complication appears in 927 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is BUPRENORPHINE (PRR 185.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Buprenorphine420185.5186.4
Buprenorphine Hydrochloride, Naloxone Hydrochloride106111.3111.8
Sevelamer Carbonate1121.721.8
Cyclosporine7917.317.3
Lisdexamfetamine Dimesylate1510.410.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.